Similar articles

• Basic approaches to anti-retroviral treatment.

  De Clercq E. De Clercq E. J Acquir Immune Defic Syndr (1988). 1991;4(3):207-18. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1704059 Review. No abstract available.
• Treatment of nonocular infections in AIDS.

  Palestine AG. Palestine AG. Int Ophthalmol Clin. 1989 Summer;29(2):89-94. doi: 10.1097/00004397-198902920-00005. Int Ophthalmol Clin. 1989. PMID: 2469664 Review. No abstract available.
• HIV envelope-CD4 interaction not inhibited by synthetic octapeptides.

  Sodroski J, Kowalski M, Dorfman T, Basiripour L, Rosen C, Haseltine W. Sodroski J, et al. Lancet. 1987 Jun 20;1(8547):1428-9. doi: 10.1016/s0140-6736(87)90613-1. Lancet. 1987. PMID: 2884513 No abstract available.
• Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein.

  Veljković V, Metlas R. Veljković V, et al. Cancer Biochem Biophys. 1988 Nov;10(2):91-106. Cancer Biochem Biophys. 1988. PMID: 2855309
• HIV infection: the cellular picture.

  Weber JN, Weiss RA. Weber JN, et al. Sci Am. 1988 Oct;259(4):100-9. doi: 10.1038/scientificamerican1088-100. Sci Am. 1988. PMID: 2854299 Review. No abstract available.